Advancing Early Detection of Alzheimer Disease in the Primary Care Setting in the United States
{{output}}
Background and objectives: As evidence supporting the robustness of blood-based biomarker (BBM) testing for Alzheimer disease (AD) continues to emerge, understanding the perceptions, drivers, and barriers to the adoption of these... ...
